Dual immune check point blockade or immune check point-tyrosine kinase inhibitor combination: as a first-line treatment in metastatic renal cell carcinoma?

Schmidinger, Manuela; Resch, Irene; Fajkovic, Harun; Remzi, Mesut; Shariat, Shahrokh F.; Bedke, Jens

dc.contributor.author	Bedke, Jens
dc.date.accessioned	2021-11-23T09:20:14Z
dc.date.available	2021-11-23T09:20:14Z
dc.date.issued	2021
dc.identifier.issn	1473-6586
dc.identifier.uri	http://hdl.handle.net/10900/120966
dc.language.iso	en	de_DE
dc.publisher	Lippincott Williams & Wilkins	de_DE
dc.relation.uri	http://dx.doi.org/10.1097/MOU.0000000000000874	de_DE
dc.subject.ddc	610	de_DE
dc.title	Dual immune check point blockade or immune check point-tyrosine kinase inhibitor combination: as a first-line treatment in metastatic renal cell carcinoma?	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210824232002_01325
utue.publikation.seiten	270-275	de_DE
utue.personen.roh	Schmidinger, Manuela
utue.personen.roh	Resch, Irene
utue.personen.roh	Fajkovic, Harun
utue.personen.roh	Remzi, Mesut
utue.personen.roh	Shariat, Shahrokh F.
utue.personen.roh	Bedke, Jens
dcterms.isPartOf.ZSTitelID	Current Opinion in Urology	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	31	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE